Vivek Ramaswamy
Net Worth

Last updated:

What is Vivek Ramaswamy net worth?

The estimated net worth of Mr. Vivek Ramaswamy is at least $717,083,769 as of 2 Jan 2024. He owns shares worth $617,960,169 as insider, has earned $98,100,000 from insider trading and has received compensation worth at least $1,023,600 in Roivant Sciences Ltd..

What is the salary of Vivek Ramaswamy?

Mr. Vivek Ramaswamy salary is $511,800 per year as Founder & Executive Chairman in Roivant Sciences Ltd..

How old is Vivek Ramaswamy?

Mr. Vivek Ramaswamy is 40 years old, born in 1985.

What stocks does Vivek Ramaswamy currently own?

As insider, Mr. Vivek Ramaswamy owns shares in one company:

Company Title Shares Price per share Total value
Roivant Sciences Ltd. (ROIV) Founder & Executive Chairman 51,929,426 $11.9 $617,960,169

What does Roivant Sciences Ltd. do?

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic anemia, thyroid eye diseases, sarcoidosis, and staph aureus bacteremia. The company was founded in 2014 and is based in London, the United Kingdom.

ROIV logo
ROIV
Roivant Sciences Ltd.
$11.9

Vivek Ramaswamy insider trading

Roivant Sciences Ltd.

Mr. Vivek Ramaswamy has made 2 insider trades between 2023-2024, according to the Form 4 filled with the SEC. Most recently he sold 6,000,000 units of ROIV stock worth $66,300,000 on 2 Jan 2024.

The largest trade he's ever made was exercising 6,000,000 units of ROIV stock on 2 Jan 2024. As of 2 Jan 2024 he still owns at least 51,929,426 units of ROIV stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Shares 6,000,000 $11.05 $66,300,000
Option
Common Shares 275,227 $12.68 $3,489,878
Option
Capped Value Appreciation Rights 251,538 N/A N/A
Option
Capped Value Appreciation Rights 611,393 N/A N/A
Option
Common Shares 119,534 $12.68 $1,515,691
Option
Capped Value Appreciation Rights 251,539 N/A N/A
Option
Capped Value Appreciation Rights 203,798 N/A N/A
Option
Common Shares 86,714 $12.68 $1,099,534
Option
Capped Value Appreciation Rights 203,798 N/A N/A
Option
Common Shares 166,057 $12.68 $2,105,603
Option
Capped Value Appreciation Rights 407,595 N/A N/A
Option
Common Shares 382,203 $12.68 $4,846,334
Option
Capped Value Appreciation Rights 1,222,787 N/A N/A
Sale
Common Shares 4,000,000 $7.95 $31,800,000

Roivant Sciences Ltd. key executives

Roivant Sciences Ltd. executives and other stock owners filed with the SEC:

  • Dr. Eric Venker M.D., Pharm.D. (38) Pres & Chief Operating Officer
  • Mr. Matthew Gline (41) Chief Executive Officer & Director
  • Mr. Vivek Ramaswamy (40) Founder & Executive Chairman